SCHEMBL1913170

SCHEMBL1913170

CC(=O)c1cc2nccn2cc1Br

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 2/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SYK P43405 1/20 0.33
MCHR1 Q99705 1/20 0.33
AURKA O14965 1/20 0.33
DAPK3 O43293 1/20 0.33
JAK2 O60674 1/20 0.33
MAP4K4 O95819 1/20 0.33
ABL1 P00519 1/20 0.33
NTRK1 P04629 1/20 0.33
CSF1R P07333 1/20 0.33
RET P07949 1/20 0.33
FGFR1 P11362 1/20 0.33
PRKACA P17612 1/20 0.33
KDR P35968 1/20 0.33
MAP2K2 P36507 1/20 0.33
MAPK8 P45983 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL339175 0.83 POLB (0.38) MAOBL3MBTL1KMT2ASYKKDR
SCHEMBL31212183 0.79 MAOB (0.37) MAOBCYP1A2MEN1KMT2AMCHR1
SCHEMBL25149802 0.75 DYRK1A (0.36) MAOBL3MBTL1CYP1A2MEN1KMT2A
SCHEMBL26359406 0.75 MAOB (0.35) MAOBCYP1A2MEN1KMT2AMCHR1
SCHEMBL24231398 0.75 POLQ (0.41) MAOBKMT2ASYKAURKADAPK3
SCHEMBL407441 0.74 L3MBTL1 (0.49) L3MBTL1CYP1A2MEN1KMT2ACDK8
SCHEMBL22717449 0.74 KMT2A (0.38) MAOBL3MBTL1CYP1A2MEN1KMT2A
SCHEMBL1913154 0.73 KEAP1 (0.38) MAOBL3MBTL1CYP1A2MEN1KMT2A
Hydrochloric Acid SCHEMBL31647268 0.73 L3MBTL1 (0.47) L3MBTL1CYP1A2MEN1KMT2AKDM4E
SCHEMBL31716869 0.72 GABRP (0.38) MAOBL3MBTL1CYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077787-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077787-A1 ORGANIC COMPOUNDS OAT, GPR119, OTC MAOB 552/4885L3MBTL1 4046/4885CYP1A2 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.